These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 659115)

  • 21. Placebo-controlled double-blind randomized trial on the use of L-carnitine, L-acetylcarnitine, or combined L-carnitine and L-acetylcarnitine in men with idiopathic asthenozoospermia.
    Balercia G; Regoli F; Armeni T; Koverech A; Mantero F; Boscaro M
    Fertil Steril; 2005 Sep; 84(3):662-71. PubMed ID: 16169400
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Therapy of male fertility disorders with kallikrein].
    Schill WB
    Dtsch Med Wochenschr; 1976 Nov; 101(48):1773-8. PubMed ID: 791606
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Evaluation of semen quality following kallikrein treatment.
    Homonnai ZT; Shilon M; Paz G
    Gynecol Obstet Invest; 1978; 9(2-3):132-8. PubMed ID: 367906
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The effects of mesterolone on sperm count in idiopathic oligospermia.
    Bhathena RK; Jassawalla MJ; Patel DN
    Int J Fertil; 1987; 32(4):306-8. PubMed ID: 2887529
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Kallikrein therapy of infertile men with varicocele and impaired sperm motility.
    Mićić S; Tulić C; Dotlić R
    Andrologia; 1990; 22(2):179-83. PubMed ID: 2264621
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Determination of various semen parameters and sex hormone levels in subfertile men during kallikrein therapy.
    Schill WB; Krizic A; Rjosk H
    Adv Exp Med Biol; 1979; 120A():537-46. PubMed ID: 495334
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Treatment of oligospermic patients with varicocele].
    Shinoda M; Naide Y; Tazaki H
    Hinyokika Kiyo; 1988 Nov; 34(11):1989-94. PubMed ID: 3149452
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Ineffectiveness of kallikrein in treatment of idiopathic male infertility: a double-blind, randomized, placebo-controlled trial.
    Keck C; Behre HM; Jockenhövel F; Nieschlag E
    Hum Reprod; 1994 Feb; 9(2):325-9. PubMed ID: 8027290
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Lack of oral kallikrein in lowering systemic blood pressure in primary hypertension.
    Bönner G; Toussaint C; Claus M; Fritschka E; Philipp T; Vetter H; Feltkamp H
    Agents Actions Suppl; 1992; 38 ( Pt 3)():294-303. PubMed ID: 1462864
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Systemic therapy of male subfertility].
    Maier U
    Wien Klin Wochenschr; 1989 Oct; 101(19):673-9. PubMed ID: 2618055
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of alfuzosin and tamsulosin on sperm parameters in healthy men: results of a short-term, randomized, double-blind, placebo-controlled, crossover study.
    Hellstrom WJ; Sikka SC
    J Androl; 2009; 30(4):469-74. PubMed ID: 19201696
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Improvement of sperm motility in patients with asthenozoospermia by kallikrein treatment.
    Schill WB
    Int J Fertil; 1975; 20(1):61-3. PubMed ID: 4389
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A placebo-controlled double-blind randomized trial of the use of combined l-carnitine and l-acetyl-carnitine treatment in men with asthenozoospermia.
    Lenzi A; Sgrò P; Salacone P; Paoli D; Gilio B; Lombardo F; Santulli M; Agarwal A; Gandini L
    Fertil Steril; 2004 Jun; 81(6):1578-84. PubMed ID: 15193480
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of kallikrein on the male reproductive system and its use in the treatment of idiopathic oligozoospermia with impaired motility.
    Giovenco P; Amodei M; Barbieri C; Fasani R; Carosi M; Dondero F
    Andrologia; 1987 Jun; 19 Spec No():238-41. PubMed ID: 3651109
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Use of kallikrein in the treatment of oligoasthenospermia].
    Mićić S; Bila S; Ilić V; Sulović V
    Srp Arh Celok Lek; 1985 Apr; 113(4):365-70. PubMed ID: 3901319
    [No Abstract]   [Full Text] [Related]  

  • 36. Kallikrein and male subfertility. Usefulness of high-unit kallikrein tablets.
    Kamidono S; Hazama M; Matsumoto O; Takada KI; Tomioka O; Ishigami J
    Andrologia; 1981; 13(2):108-20. PubMed ID: 6910373
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Tamoxifen and kallikrein in therapy of oligoasthenozoospermia: results of a randomized study.
    Maier U; Hienert G
    Eur Urol; 1990; 17(3):223-5. PubMed ID: 2190839
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Potentialities and limitations of endocrine treatment in idiopathic oligozoospermia.
    Lunglmayr G
    Acta Eur Fertil; 1983; 14(6):401-4. PubMed ID: 6426233
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Carnitine for the treatment of idiopathic asthenospermia: a randomized, double-blind, placebo-controlled trial.
    Sigman M; Glass S; Campagnone J; Pryor JL
    Fertil Steril; 2006 May; 85(5):1409-14. PubMed ID: 16600222
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Kallikrein therapy in asthenozoospermia].
    Neumann J; Glander HJ; Schreiber G; Engel S
    Dermatol Monatsschr; 1985; 171(2):102-5. PubMed ID: 3845023
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.